Hosted on MSN

Medtronic’s INFUSE Bone Graft trial meets predefined early success criteria

Medtronic has announced that an independent Data Monitoring Committee (DMC) reviewed the initial interim analysis and confirmed that the randomised controlled trial of INFUSE Bone Graft in the ...
Nasdaq

Medtronic Announces New Clinical Trial to Study Infuse Bone Graft in TLIF Spine Procedures

DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced U.S. FDA approval of a prospective, randomized pivotal clinical trial for the use of Infuse™ Bone Graft ...
Yahoo Finance

NuVasive Launches Titanium Spine Implant Modulus TLIF-O

NuVasive, Inc. NUVA recently announced the commercial launch of Modulus TLIF-O, a porous titanium spine implant. The system is designed for the transforaminal lumbar interbody fusion (TLIF) procedure.
Business Wire

Orthofix Announces FDA Clearance and First Patient Implant of the 3D-Printed FORZA Titanium TLIF Spacer System with Nanovate Technology

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. Food and Drug Administration 510(k ...
Stockhouse

Medtronic Announces New Clinical Trial to Study Infuse Bone Graft in TLIF Spine Procedures

DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced U.S. FDA approval of a prospective, randomized pivotal clinical trial for the use of Infuse™ Bone Graft ...